Dovitinib
Oncology Venture advancing in all priority programs
Treatment outcomes in cancer care could be significantly improved if there was a way to identify whether or not...
New CEO in Oncology Venture has a stronger commercial market focus
Recently, Oncology Venture stepped up in management and...
Oncology Venture utökar sitt ägande i dovitinib
Förra veckan förvärvade Oncology Venture ytterligare 8 procents...
Nyhetssvepet torsdag 13 juni
Ett redaktionellt urval av dagens Life Science-nyheter
